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Abstract
Background: Biotin is an essential enzyme cofactor that acts as a CO2 carrier in carboxylation and decarboxylation
reactions. The E. coli genome encodes a biosynthetic pathway that produces biotin from pimeloyl-CoA in four
enzymatic steps. The final step, insertion of sulfur into desthiobiotin to form biotin, is catalyzed by the biotin
synthase, BioB. A dedicated biotin ligase (BirA) catalyzes the covalent attachment of biotin to biotin-dependent
enzymes. Isotopic labeling has been a valuable tool for probing the details of the biosynthetic process and
assaying the activity of biotin-dependent enzymes, however there is currently no established method for 35S
labeling of biotin.
Results: In this study, we produced [35S]-biotin from Na35SO4 and desthiobiotin with a specific activity of 30.7 Ci/
mmol, two orders of magnitude higher than previously published methods. The biotinylation domain (PfBCCP-79)
from the Plasmodium falciparum acetyl-CoA carboxylase (ACC) was expressed in E. coli as a biotinylation substrate.
We found that overexpression of the E. coli biotin synthase, BioB, and biotin ligase, BirA, increased PfBCCP-79
biotinylation 160-fold over basal levels. Biotinylated PfBCCP-79 was purified by affinity chromatography, and free
biotin was liberated using acid hydrolysis. We verified that we had produced radiolabeled biologically active
[D]-biotin that specifically labels biotinylated proteins through reuptake in E. coli.
Conclusions: The strategy described in our report provides a simple and effective method for the production of
[35S]-biotin in E. coli based on affinity chromatography.
Background
Biotin, or vitamin H, was first identified as a yeast growth
factor over 100 years ago [1] and was subsequently iso-
lated from egg yolk [2] and liver [3]. It is an essential
cofactor for a small family of enzymes that catalyze car-
boxylation and decarboxylation reactions, in which biotin
serves as a covalent attachment site for CO2 [4]. The
number of biotinylated proteins varies from one to five in
different organisms [5]. Biotin-dependent enzymes
include acetyl-CoA carboxylase, pyruvate carboxylase,
propionyl-CoA carboxylase, methylcrotonyl-CoA carbox-
ylase, geranoyl-CoA carboxylase, oxaloacetate decarboxy-
lase, methylmalonyl-CoA decarboxylase, transcarboxylase
and urea amidolyase [6]. These enzymes participate in
central metabolic processes such as gluconeogenesis,
lipogenesis, amino acid metabolism and energy transduc-
tion. The most widespread biotin-dependent enzyme is
acetyl-CoA carboxylase (ACC) [7], which catalyzes the
ATP-dependent transfer of a carboxyl group from carbo-
nate to acetyl-CoA to form malonyl-CoA, in the first
committed step of fatty acid biosynthesis [8].
ACC is the only biotinylated enzyme in Escherichia
coli [9], and it exists as a complex of four proteins: bio-
tin carboxylase (BC), carboxyl transferase alpha and beta
chains (CT), and biotin carboxy carrier protein (BCCP)
[10]. The BC subunit is responsible for transferring a
carboxyl group from a substrate (carbonate) to the bio-
tin prosthetic group, which is covalently attached to a
conserved lysine in the BCCP subunit [11]. The CT
serves to transfer the carboxyl group from biotin to
acetyl-CoA, forming malonyl-CoA [12]. Biotin is
attached to BCCP by a dedicated biotin protein ligase,
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BirA. This enzyme catalyzes the ATP-dependent forma-
tion of an amide linkage between the carboxyl group of
biotin and the ε-amino group of a specific lysine residue
in BCCP [4]. The primary structure of biotinylation
domains exhibits a high degree of similarity across spe-
cies. The biotinylated lysine residue occurs in a con-
served AMKM tetrapeptide, and a minimum of 75-80
residues surrounding this motif are required for recogni-
tion by BirA. Biotin protein ligases show significant
cross reactivity between species, i.e. bacterial ligases bio-
tinylate mammalian apo-proteins, and vice versa [4].
E. coli can scavenge biotin from the environment, or
synthesize it de novo from a pimeloyl-CoA precursor.
The enzymes of the biosynthetic pathway are encoded
by the bio operon (bioABCFD) [13]. The final step,
insertion of sulfur into desthiobiotin to form biotin, is
catalyzed by biotin synthase (BioB). This enzyme con-
tains two iron-sulfur clusters, a [4Fe-4S] cluster com-
mon to all radical SAM (S-adenosyl-L-methionine)
enzymes which facilitates the reductive cleavage of SAM
[14], and a [2Fe-2S] cluster which donates the sulfur
atom to desthiobiotin [15].
The metabolic origins of biotin and its attachment to
proteins have been tracked using carbon, sulfur and
hydrogen isotopes [16-18]. Currently [3H]-biotin is com-
mercially available, but is not feasible to use as a meta-
bolic label in some systems due to the low sensitivity of
3H. Previous attempts have been made to label biotin
with 35S using intact cells of Saccharomyces cerevisiae
[19], Aspergillus niger [20] and Rhodotorula glutinis [21],
however these attempts were hampered by poor yield,
low specific activity of biotin, or the predominance of
oxidized biotin species.
We developed a strategy to synthesize [35S]-biotin
from desthiobiotin and Na35SO4 in E. coli (Figure 1).
We expressed a 79-residue biotinylation domain
(PfBCCP-79) from the Plasmodium falciparum ACC
protein, and purified PfBCCP-79 by affinity chromato-
graphy. We found that coexpression of the E. coli bio-
tin synthase, BioB, increased PfBCCP-79 biotinylation
over basal levels, however, coexpression of both BioB
and the E. coli biotin ligase, BirA, was required for effi-
cient biotinylation of PfBCCP-79. In these experiments,
the BioB expression plasmid could not be substituted
with a plasmid expressing the Azotobacter vinelandii
Isc (Iron Sulfur Cluster) proteins, suggesting that
remetalation of endogenous BioB did not significantly
increase biotin synthase activity. Biotin was liberated
from pure PfBCCP-79 using acid hydrolysis, and was
quantified in a bioassay based on the growth of a bio-
tin auxotroph E. coli strain. We measured reuptake of
biotin in E. coli to verify that we had produced biologi-
cally active, radiolabeled [D]-biotin, and found that we
were able to specifically label the E. coli BCCP. From a
10 ml culture of cells supplemented with 1 mCi
Na35SO4 we obtained 37 pmol of [
35S]-biotin, with a
specific activity of 30.7 Ci/mmol.
Results and Discussion
Expression of a biotin-domain in E. coli
Biotin biosynthesis in E. coli is a tightly regulated process,
and results in about 200 molecules of protein-bound bio-
tin per cell [22]. To increase the yield of biotin produc-
tion in E. coli, we expressed a biotin carrier protein,
which contained an affinity tag to aid in its purification.
Both E. coli and the malaria parasite Plasmodium falci-
parum encode a single biotinylated protein in their gen-
ome, the acetyl-CoA carboxylase (ACC). In E. coli, the
enzyme exists as a complex of four proteins, while in P.
falciparum, the ACC is a single large polypeptide.
Despite the difference in structure, the domains of the P.
falciparum ACC are homologous to the protein subunits
of the E. coli ACC complex. Biotin is conjugated to a par-
ticular lysine in the biotin carboxy carrier protein (BCCP)
domain. We selected the P. falciparum BCCP as a bioti-
nylation substrate because it does not contain cysteine
residues, which would incorporate the 35S label and com-
plicate the purification and quantification of radiolabeled
biotin. The E. coli BCCP contains a single cysteine
at amino acid 116, which is only four amino acids
away from the conserved AMKM biotinylation motif.
Figure 1 Synthesis of radiolabeled biotin in E. coli. The E. coli
biotin synthase (BioB) catalyzes the insertion of sulfur into
desthiobiotin to form biotin, which is then ligated to the biotin
carboxy carrier protein (BCCP) by the biotin protein ligase (BirA). The
sulfur is donated from a [2Fe-2S] cluster on BioB which is formed by
iron sulfur cluster biogenesis (Isc) proteins. E. coli supplemented
with desthiobiotin and 35SO4 will produce small quantities of
radiolabeled biotin bound to BCCP. The P. falciparum BCCP, which
does not contain the amino acid cysteine, was overexpressed in the
methionine auxotroph E. coli strain B834(DE3) to prevent the
incorporation of 35S into the BCCP protein. BirA, BioB and the Isc
proteins were overexpressed to increase the yield of radiolabeled
biotin.
Delli-Bovi et al. BMC Biotechnology 2010, 10:73
http://www.biomedcentral.com/1472-6750/10/73
Page 2 of 11
Therefore, mutation of this residue may interfere with
the folding of the protein or the biotinylation reaction.
The ~80-residue biotinylation sites of the BCCP ortho-
logs share 48% sequence similarity, so we expected that
the E. coli biotin ligase would recognize and biotinylate
the P. falciparum protein in vivo.
Initially, the entire 214-residue BCCP domain (PfBCCP)
of the P. falciparum ACC was cloned into a modified
pGEX-4T-3 vector (pGEXT), which encodes a GST fusion
protein that can be cleaved by tobacco etch virus (TEV)
protease. Expression tests in E. coli indicated that the full-
length PfBCCP domain was insoluble (Figure 2A, lane 1).
We then cloned only the C-terminal 79 residues of BCCP
(PfBCCP-79) into pGEXT, and when we expressed this
fragment in E. coli we found that it was soluble (Figure 2A,
lane 4). These residues correspond to the 80-residue bioti-
nylation domain found in the crystal structure of E. coli
BCCP [PDB:1BDO]. Chapman-Smith and coworkers
demonstrated that a similar fragment, the C-terminal 87
residues of E. coli BCCP, acts as a stable domain that is
biotinylated in vivo by the biotin ligase, BirA [23].
PfBCCP-79 was expressed as a GST fusion protein in
BL21-Star(DE3) cells, and purified by affinity chromato-
graphy on a glutathione-Sepharose column, yielding 110
mg of protein from 1 L of culture (Figure 2B, lane 1).
The fusion protein was cleaved in vitro by TEV protease
(lane 2) and the sample was reapplied to the column to
remove free GST. Our final sample did not contain any
contaminants visible by Coomassie blue staining, except
for a faint band corresponding to free GST (lane 3).
Purified PfBCCP-79 was concentrated to 1.2 g/L, and
used for the production of specific antisera in rabbits.
Because the GST fusion protein is not ideal for label-
ing with 35S, due to the presence of multiple cysteines
that would incorporate the radiolabel, we also expressed
PfBCCP-79 with an N-terminal six-histidine tag from
plasmid pTDe010. pTDe010 encodes His6-tagged
PfBCCP-79 under control of a T7 promoter, with a
kanamycin resistance cassette and a pMB1 origin of
replication. His6-tagged PfBCCP-79 was expressed in
BL21-Star(DE3) cells, and purified on a metal chelate
column charged with NiCl2, yielding 90 mg of protein
from 2 L of culture (Figure 2B, lane 4). These data
demonstrate that PfBCCP-79 is soluble, expressed at
high levels, and can be purified with high yield by affi-
nity chromatography.
Biotinylation of PfBCCP-79
In order to evaluate whether PfBCCP-79 is a valid biotin
carrier for the purification of [35S]-biotin from E. coli,
we tested whether it is biotinylated efficiently by the
E. coli biotin ligase, BirA. It has been shown that
EcBCCP is not efficiently biotinylated when it is overex-
pressed, unless it is coexpressed with BirA [23]. In order
to assess whether this was the case for PfBCCP-79, we
measured biotinylation levels of PfBCCP-79 in cells that
overexpress BirA from plasmid pCY216 [23], which
encodes the E. coli birA gene under control of an arabi-
nose-inducible promoter in a chloramphenicol resistant
plasmid. We considered expressing a cognate biotin
ligase from P. falciparum, however, malaria parasites
appear to encode two BirA paralogs (PF10_0409 and
PF14_0573) and it is not clear which enzyme would be
the appropriate ligase for PfBCCP-79. We therefore
chose to rely on the fact that there is a high level of
cross-reactivity between biotin ligases and biotinylated
proteins from divergent species [4].
All experiments were carried out using the methionine
auxotroph E. coli strain B834(DE3). Although protein
expression levels in this cell line were lower than in
BL21-Star(DE3) cells, it was necessary to use a methio-
nine auxotroph in order to prevent incorporation of 35S
into methionine. The methionine residues cannot be
mutated from BCCP proteins since the AMKM biotiny-
lation site contains methionine amino acids. Cells were
transformed with expression vectors pTDe010 and
pCY216. Cultures of these cells were grown to log
phase, protein expression was induced with IPTG and
arabinose, and the cultures were supplemented with the
Figure 2 Expression and solubility of PfBCCP. (A) Coomassie-
stained SDS-PAGE gel showing soluble and insoluble fractions from
cells expressing full length or truncated PfBCCP. The full-length 214-
residue biotin carboxy carrier protein (BCCP) domain of the P.
falciparum ACC gene (PfBCCP) and a 79-residue fragment
containing the biotinylation site (PfBCCP-79) were expressed as GST
fusion proteins in BL21-Star(DE3) cells. Whole cell lysate was
separated into insoluble (pellet) and soluble (sol) fractions by
centrifugation. The truncated fragment was predominantly soluble.
(B) SDS-PAGE gel showing GST-tagged PfBCCP-79 (GST-BCCP)
purified by affinity chromatography on a GSTrap™ Fast-Flow column
(lane 1) and cleaved in vitro by tobacco etch virus (TEV) protease
(lane 2). The sample was reapplied to the column to remove free
GST and the purified protein (lane 3) was used for production of
antisera in rabbits. PfBCCP-79 was also purified with a six-histidine
tag (His-BCCP) on a metal chelating column charged with NiCl2
(lane 4).
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biotin precursor desthiobiotin. Cells were harvested and
biotinylation of PfBCCP-79 was measured by affinity
blotting using streptavidin-HRP (Figure 3, upper and
middle panels). This probe also detected the endogenous
EcBCCP. As expected, levels of biotinylated EcBCCP did
not change between any of the conditions we tested,
since EcBCCP is fully biotinylated under normal condi-
tions [24].
We found that overproduction of BirA did not appear to
effect the efficiency of PfBCCP-79 biotinylation (Figure 3,
lane 1). This may be explained by the transcriptional regu-
lation function of BirA. When BCCP is fully saturated
with biotin the BirA-biotinyl-AMP intermediate accumu-
lates, promoting the cooperative dimerization of BirA; this
complex binds to the biotin operator and represses tran-
scription of biotin biosynthetic genes [25,26]. In this way,
biotin synthesis and protein biotinylation are tightly
coupled, and there is little free intracellular biotin [27].
Overexpression of BirA may increase the amount of the
repressor species, and thus shut down biotin biosynthesis.
This hypothesis implies that the dynamics of biotinylation
differ between the E. coli and P. falciparum substrates,
that is, if the efficiency of PfBCCP-79 biotinylation is sig-
nificantly slower than that of EcBCCP, the BirA-biotinyl-
AMP repressor will accumulate even in the presence of
excess apo-PfBCCP-79. The fact that EcBCCP biotinyla-
tion levels did not change between different conditions
supports this model.
To circumvent this problem, we coexpressed PfBCCP-79
with both BirA and the biotin synthase, BioB. BioB cata-
lyzes the final step in the biotin biosynthetic pathway, the
insertion of sulfur into desthiobiotin to form biotin [28].
We measured PfBCCP-79 biotinylation in cells expressing
BioB from plasmid pSPr059, which encodes the E. coli
bioB gene under control of the lPL/tetO promoter in an
ampicillin resistant plasmid. We found that coexpression
of PfBCCP-79 with BioB alone increased biotinylation 16-
fold over the level seen with BirA alone (Figure 3, lane 2),
while coexpression with both BioB and BirA resulted in an
additional 10-fold increase in biotinylation (lane 4).
BioB donates sulfur from a [2Fe-2S] cluster to desthio-
biotin in a suicide mechanism [29]. If regeneration of the
iron-sulfur cluster is a limiting step in this pathway, then
biotinylation efficiency can be increased by facilitating the
remetalation of BioB. The Isc (Iron Sulfur Cluster) pro-
teins from Azotobacter vinelandii comprise the iron-sulfur
cluster biogenesis pathway in this organism [30] and have
been shown to increase the yield of properly metalated
biotin synthase when expressed in E. coli [31]. We tested
the effect on biotinylation levels when we added plasmid
pDB1282 to our cell line, which encodes the essential
genes of the Isc operon from A. vinelandii (iscS, iscU, iscA,
hscB, hscA and fdx) [30] under control of an arabinose-
inducible promoter with an ampicillin resistance cassette.
We found that overproduction of PfBCCP-79 with the
AvIsc proteins, either alone or in combination with BirA,
did not have a significant effect on biotinylation levels
(Figure 3, lanes 3 and 5). These results indicate that reme-
talation of endogenous BioB by the Isc proteins was less
effective in promoting biotin synthesis than overexpression
of BioB, and thus the formation of iron-sulfur clusters on
BioB is not a limiting step in biotin synthesis.
An alternative explanation is that the AvIsc proteins are
not expressed at sufficient levels to affect PfBCCP-79 bio-
tinylation. These experiments were carried out in mini-
mal media containing glucose as the carbon source. Since
glucose inhibits the uptake of pentose sugars such as ara-
binose [32], the induction of BirA and the AvIsc proteins
could be affected by this medium. We conducted the
experiments shown in Figure 3 substituting glucose with
0.4% glycerol and found that biotinylation in cells expres-
sing BirA tripled, however, there was no effect in cells
expressing the AvIsc proteins, and only a modest increase
of 8% in cells expressing both BirA and BioB (data not
shown). Thus, removing glucose from the medium does
slightly increase biotinylation due to increased expression
of BirA, but not AvIsc proteins. Although glucose does
affect the expression of BirA by arabinose, the long low
Figure 3 Biotinylation of PfBCCP-79. Western blot analysis of
B834(DE3) E. coli cell lysate from cultures expressing his6-tagged
PfBCCP-79, in combination with either the E. coli biotin ligase, BirA,
the E. coli biotin synthase, BioB, or the iron sulfur cluster (Isc)
proteins from Azotobacter vinelandii. Biotinylation levels of the E. coli
BCCP (17kDa) and P. falciparum BCCP (11kDa) were assessed by
affinity blotting with streptavidin-HRP (SA-HRP, upper panel).
Biotinylation can be enhanced 160-fold by coexpressing PfBCCP-79
with BirA and BioB. Loading samples ten times more concentrated
shows that there was some biotinylation under all conditions (SA-
HRP 10X load, middle panel). Re-probing the blot with PfBCCP
antiserum shows that PfBCCP-79 was expressed at similar levels in
all samples (a-BCCP, bottom panel).
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temperature induction used in our experiments largely
compensates for this effect. Indeed, we observe protein
bands by SDS-PAGE corresponding to BirA and certain
Isc proteins which are only present after induction with
arabinose (data not shown).
Loading samples ten times more concentrated showed
that there was some biotinylated PfBCCP-79 under all
the conditions tested (Figure 3, middle panel). Western
blot analysis using PfBCCP antiserum showed that the
protein is expressed at similar levels in all the cultures
(Figure 3, lower panel). Together, these results indicate
that PfBCCP-79 can be expressed in E. coli, and is bio-
tinylated by the E. coli biotin ligase. We can increase the
yield of biotin production by overexpressing key
enzymes of the biosynthetic pathway. We bypassed the
negative feedback loop that regulates the biotin operon
by overexpressing the biotin synthase, BioB, under a
constitutive promoter, and supplementing the culture
with the BioB substrate, desthiobiotin. We found that it
was also necessary to overexpress the biotin ligase, BirA,
for efficient biotinylation of PfBCCP-79.
Purification of PfBCCP-79
We purified His6-tagged PfBCCP-79 from whole cell lysate
using affinity chromatography. We expressed PfBCCP-79
in B834(DE3) cells, together with BioB and BirA. Cells
were grown to log phase at 37°C and protein expression
was induced with IPTG and arabinose. Cultures were
transferred to 20°C, and after one hour, the substrate
desthiobiotin was added. They were maintained at 20°C
for an additional 10 hours, after which cells were harvested
and lysed. Cell lysate was cleared by centrifugation and
applied to a metal chelate column charged with NiCl2.
The column was washed with 30 mM imidazole, 1 M
NaCl, and 1% Triton X-100 to remove proteins that inter-
act weakly or non-specifically. Bound proteins were then
eluted with 400 mM imidazole onto a column packed
with monomeric avidin resin, and the column was washed
with buffer. Bound proteins were eluted with 50 mM gly-
cine pH 2.9, which denatures the avidin so that it releases
biotin. It is typical to elute from an avidin column with
high concentrations of biotin, but this is undesirable in
our case since it would add large amounts of unlabeled
biotin to the sample. The advantage of using avidin resin
is that it separates apo-PfBCCP-79 from holo-PfBCCP-79,
allowing us to estimate the proportion of the protein
that is biotinylated. The unbiotinylated protein was col-
lected in the flow through from the avidin affinity column
(Figure 4A, lane 4), while the biotinylated protein was
collected in the elution fractions (Figure 4A, lanes 6 and
7). Samples collected at each step in the purification were
separated by SDS-PAGE and stained with Coomassie
Blue dye, and densitometry analysis was carried out using
ImageJ [33,34].
By comparing the flow through (FT2) and elution
fractions (E1/E2) from the avidin column, we estimated
that 40% of the PfBCCP-79 from the metal chelate col-
umn was binding to the avidin column. This suggests
that in vivo less than half of the protein is biotinylated,
or alternatively, that biotinylated protein did not bind to
the column for some reason. To address this question,
we transferred the proteins to nitrocellulose membrane
for affinity blotting using streptavidin-HRP. No biotiny-
lated proteins were detected in FT2, confirming that the
unbound PfBCCP-79 was not biotinylated (Figure 4B).
This experiment also revealed that approximately half
(49%) of the biotinylated protein did not bind to the
metal chelate column (Figure 4B, lane 2), perhaps due
to slow kinetics of binding. To address this question, we
reapplied the flow through to a clean metal chelate col-
umn, and observed that no additional PfBCCP-79 bound
the column (data not shown). Thus, this protein cannot
bind to the column, probably due to degradation of the
affinity tag. Indeed, the lower band near 6 kDa in FT1 is
likely a degradation product of biotinylated PfBCCP-79.
One way to address this problem, and increase the yield
from the purification, would be to tag the protein on
both the N- and C-termini. We estimated that 18% of
Figure 4 Purification of PfBCCP-79. PfBCCP-79 was coexpressed
with BirA and BioB in B834(DE3) cells and purified by affinity
chromatography. (A) Coomassie-stained SDS-PAGE gel showing
fractions collected from each purification step. (B) Affinity blot using
streptavidin-HRP to detect biotinylated proteins. Biotinylated
PfBCCP-79 was present in the flow through from the metal chelate
column and in the elution. The gel samples are labeled as follows:
column input (CI); flow through from metal chelate column (FT1);
30 mM imidazole wash (W1); flow through from monomeric avidin
column (FT2); buffer wash (W2); elution in 50 mM glycine pH 2.9
(E1); elution in 50 mM glycine pH 1.9 (E2).
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the PfBCCP-79 present in the cell lysate was recovered
in the elution. Overall, these data show that PfBCCP-79
is a valid biotinylation substrate in E. coli and can be
purified from cell lysate by affinity chromatography.
Production of [35S]-biotin
After validating the conditions for purifying His6-tagged
PfBCCP-79 from E. coli, we used this procedure to gen-
erate [35S]-biotin. We grew 10 ml cultures of B834(DE3)
cells to log phase at 37°C, then transferred the cultures
to 20°C and induced protein expression with IPTG and
arabinose. After one hour, 1 mM of the biotin precursor
desthiobiotin and 1 mCi of Na35SO4 were added to the
culture. The culture was maintained at 20°C for an addi-
tional 10 hours. Cells were then harvested and His6-
tagged PfBCCP-79 was purified from whole cell lysate as
described above. Samples from each step of the purifica-
tion were collected and analyzed by SDS-PAGE and
autoradiography (Figure 5A). The 11.3 kDa band in the
elution (E1) corresponds to [35S]-biotin-PfBCCP-79. The
only source of radioactivity in the protein should be
from the biotin prosthetic group, because PfBCCP-79
has no cysteines that could incorporate the radiolabel,
and the B834(DE3) strain is a methionine auxotroph
and can only utilize the unlabeled methionine added to
the medium. Therefore, the band of similar size to
PfBCCP-79 in FT2 is either another protein of unknown
identity, or biotinylated BCCP in which the biotin has
been damaged in such a way that it is not recognized by
avidin. Affinity blotting using streptavidin-HRP showed
that there is no detectable biotinylated PfBCCP-79 in
FT2 (Figure 5B).
We also analyzed these samples using anti-PfBCCP
antiserum (Figure 5C). The antiserum detected the same
~6 kDa band in FT1 that we observed in the previous
experiment. This indicates that the fragment is a degra-
dation product of the PfBCCP-79 fusion protein, and
not derived from the endogenous E. coli BCCP. This
band is also present in the purified sample (E1), suggest-
ing that some degradation occurs during the purification
process. We carried out densitometry analysis of this
western blot to determine the proportion of PfBCCP-79
present in each sample, and our results were consistent
with those from the previous experiment. We estimated
that 56% of the protein did not bind the MC column
(versus 49% in the previous experiment), and was col-
lected in FT1. An additional 6% was removed in the
first wash with 30 mM imidazole. The remaining unbio-
tinylated PfBCCP-79 was collected in the flow through
from the avidin column, which amounted to 18% of
total protein. Our purified sample contained 21% of the
starting amount of PfBCCP-79 in the cell lysate (com-
pared to 18% in the previous experiment), correspond-
ing to 9.9 μg of PfBCCP-79. We also repeated our
calculation of the biotinylation efficiency based on these
results. We estimated that 54% of the total PfBCCP-79
was biotinylated, which was higher than our previous
estimate of 40%. This difference may be due to differ-
ences between the two experiments, or error associated
with comparing results between SDS-PAGE and western
blot images.
Verification and quantification of biologically active
[35S]-biotin in E. coli
Acid hydrolysis was used to degrade proteins in the
sample, thus liberating free biotin. We digested both
FT1 and E1 in 5 M HCl for 8 hours at 95°C. FT1 served
as the negative control, since this sample contained pro-
teins that have incorporated 35S-labeled cysteine resi-
dues. We compared these samples before and after
hydrolysis using SDS-PAGE and autoradiography. The
disappearance of all bands in both samples after hydro-
lysis shows that proteins were completely digested
under these conditions (Figure 6A). We then wished to
verify that the [35S]-biotin we produced was biologically
available to the cell. To this end, we used the biotin
auxotroph E. coli strain Keio JW0758 in which the bio-
tin synthase (bioB) gene had been replaced with a
Figure 5 Purification of [35S]-biotinylated PfBCCP-79. PfBCCP-79
was coexpressed with BirA and BioB in B834(DE3) cells in the
presence of Na35SO4 and desthiobiotin, and purified by affinity
chromatography. (A) Autoradiograph of a SDS-PAGE gel showing
samples collected at each purification step. (B) Affinity blot analysis
with streptavidin-HRP to detect biotinylated proteins. (C) Western
blot analysis with PfBCCP antiserum. The gel samples are labeled as
follows: flow through from metal chelate column (FT1); 30 mM
imidazole wash (W1); 1 M NaCl wash (W2); 1% triton X-100 wash
(W3); flow through from monomeric avidin column (FT2); buffer
wash (W4); elution in 50 mM glycine pH 2.9 (E1).
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kanamycin resistance cassette [35,36], similar to the
strain employed by Hwang and coworkers [37]. We sup-
plemented cultures of ΔbioB E. coli with either the FT1
or E1 hydrolysate. Cells were cultured in minimal media
with no other source of biotin. Both protein hydroly-
sates were able to support cell growth, due to the
presence of biotinylated PfBCCP-79 and EcBCCP in
FT1. The cells were harvested, and proteins were sepa-
rated by SDS-PAGE and analyzed by autoradiography.
In cultures supplemented with E1 hydrolysate, a single
band appeared on the autoradiograph, which corre-
sponded in size to the 17 kDa E. coli BCCP. In contrast,
cultures supplemented with FT1 hydrolysate incorpo-
rated [35S]-cysteine into all newly synthesized proteins
(Figure 6B). These results demonstrate that the radiola-
beled biotin in the sample is biologically active and
available to cellular enzymes, and specifically labels bio-
tinylated proteins.
The hydrolysate containing [35S]-biotin may be used
directly for biotin labeling experiments, as the only
source of radioactivity in the sample is from biotin.
However, in some cases it may be desirable to further
purify biotin from the hydrolyzed protein and other
material in the sample. Silica gel flash chromatography
or high performance liquid chromatography (HPLC)
would be most suitable for this purpose.
We developed an assay to quantify the amount of biotin
in the sample, using the same ΔbioB E. coli strain. If this
strain is supplemented with known concentrations of bio-
tin, it will grow at a rate proportional to the biotin in the
culture, over a small range of biotin concentrations
(between 0 pM and 400 pM). Based on the biotin concen-
trations that limited growth, we estimated that about 250
molecules of biotin are required per E. coli cell, in close
agreement with a previous estimation of 200 molecules
per cell [22]. These cultures were used to construct a stan-
dard growth curve (Figure 6C). Cultures supplemented
with serial dilutions of the hydrolysate were grown in par-
allel, and the optical density of these cultures was com-
pared to the standard curve in order to determine the
concentration of biotin in the original sample. We found
that a 2 mL culture of ΔbioB E. coli supplemented with
5 μl of PfBCCP-79 hydrolysate grew to an OD600 of 0.62.
We estimated that this culture contained 185 pM biotin
based on comparison to the biotin standard curve depicted
in Figure 6C. Thus, we obtained 37 pmol of biotin from
the original 10 mL E. coli culture, and the specific activity
of [35S]-biotin produced by our method is 30.7 Ci/mmol.
In a previous attempt to label biotin with 35S in Aspergillus
niger, Shimada and coworkers reported a specific activity
of only 0.41 Ci/mmol [20]. We have thus achieved an
increase in sensitivity of two orders of magnitude, which is
a significant advantage for the detection of biotinylated
molecules that are usually present at low intracellular con-
centrations. Although antibodies are available that can
measure biotin, radiolabeled biotin is a more sensitive
probe, and can be more accurately quantified. In addition,
only radiolabeled biotin can track a specific population of
biotin, and differentiate between newly synthesized biotin
and biotin that is scavenged from the growth media.
Figure 6 Liberation of biologically active [35S]-biotin, and its
verification and quantification in E. coli. (A) Autoradiograph of a
SDS-PAGE gel showing acid hydrolysis of the flow through from the
metal chelate column (FT1) and the elution fraction containing
35S-labeled PfBCCP-79 (E1). (B) Autoradiograph of cell lysate from a
ΔbioB E. coli strain cultured with the protein hydrolysates shown in
panel A. The 17 kDa BCCP protein from E. coli is specifically labeled
by the E1 hydrolysate, showing that [35S]-biotin is taken up and
incorporated into cellular proteins. (C) Standard curve showing cell
growth of ΔbioB E. coli cultures supplemented with increasing
concentrations of biotin. This curve was used to quantify the
concentration (indicated by the red line) of [35S]-D-biotin produced.
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Conclusions
We developed a simple and effective strategy for the
production of [35S]-biotin in E. coli. We have shown
that a 79-residue fragment of the P. falciparum BCCP
functions as a biotinylation substrate in vivo, and
that the biotinylation efficiency of PfBCCP-79 can be
enhanced by overproduction of the E. coli biotin
synthase, BioB, and biotin ligase, BirA. Biotinylated
PfBCCP-79 was purified from whole cell lysate using
affinity chromatography, and free biotin was liberated by
acid hydrolysis. We measured the reuptake of biotin in
E. coli in order to quantify the biotin in the sample, and
to verify that we had produced biologically active, radi-
olabeled [D]-biotin, which specifically labels cellular
proteins.
Methods
Plasmid constructs for expression of PfBCCP
The expression vector pGEXT was constructed from
pGEX-4T-3 (GE Healthcare) by replacing the sequence
encoding the thrombin cleavage site (beginning at base
918) with that of the tobacco etch virus (TEV) protease.
This was done with the QuikChange site-directed muta-





(TEV cleavage site shown in lower case). The resulting
vector, pGEXT, produces a glutathione S-transferase
(GST) fusion protein which can be cleaved by TEV
protease.
The biotin carboxy carrier protein (BCCP) domain
(residues 1156-1369) of the P. falciparum acetyl-CoA
carboxylase (ACC) gene [GenBank:XM_001348802;
PlasmoDB:PF14_0664] was amplified by PCR from
cDNA of P. falciparum 3D7 erythrocyte stages, using
primers BCCP1, 5’-GGTGGTGGATCCTTATGTGC-
TACCATATTTAAACTATTAATATATTTTATG-3’
and BCCP2, 5’-GGTG GTCTCGAGTTATTCTAT-
TATTCCTAATAAATCTCCTATTTTAATAATTG-3’.
The PCR product was digested with BamHI and XhoI
(underlined) and ligated into the pGEXT vector digested
with the same endonucleases, generating plasmid
pMSp038. The resulting fusion protein (PfBCCP) con-
tained the entire BCCP domain with an N-terminal
GST tag. In order to test for solubility of the fusion
protein, 100 ml cultures were grown to an OD600 of
0.6, protein expression was induced with IPTG, and the
cultures were incubated for an additional three hours at
37°C. Cells were lysed, and whole cell lysate was centri-
fuged to separate the soluble and insoluble fractions.
The PfBCCP fusion protein was found in the insoluble
fraction. A second construct was designed (PfBCCP-79)
based on the biotinylation domain found in the crystal
structure of the E. coli BCCP [PDB:1BDO] [38]. Nucleo-
tides encoding ACC residues 1291-1369 were amplified
from pMSp038 using primers BCCP3, 5’-GGTG GT
GGATCCGATAATATTTTCATACCTAAT GTT AGG
AATCC-3’ and BCCP2, digested with BamHI and XhoI
and ligated into the pGEXT vector, generating plasmid
pTDe003. Expression tests using pTDe003 indicated
that the resulting GST fusion protein was soluble.
PfBCCP-79 was purified from E. coli (see below) and
used for the generation of specific antisera in rabbits.
Purification of PfBCCP-79 for generation of rabbit antisera
Plasmid pTDe003, encoding GST-tagged PfBCCP-79,
was transformed into BL21-Star(DE3) cells (Invitrogen)
previously transformed with the pRIL plasmid isolated
from BL21-CodonPlus(DE3) cells (Stratagene). pRIL
encodes rare tRNAs that aid in the expression of P. fal-
ciparum proteins in E. coli. Cells were grown to an
OD600 of 0.8 in LB medium at 37°C, and then protein
expression was induced with 0.4 mM IPTG and the cul-
tures were maintained at 20°C for 10 hrs. Cells were
harvested by centrifugation at 4,000 g for 20 min at 4°C
followed by resuspension in 20 mL of lysis buffer (phos-
phate buffered saline (PBS) solution pH 7.5, 1 mg/mL
lysozyme, 2.5 μg/mL DNAse I, 10 mM PMSF, 10 mM
DTT) per liter of cell culture. The resuspended cell mix-
ture was sonicated, and then cleared by centrifugation at
30,000 g for 20 min at 4°C. Cleared supernatant was
loaded on a GSTrap™ Fast-Flow chromatography col-
umn (GE Healthcare) equilibrated in PBS pH 7.5. After
washing with 5 column volumes of PBS, GST fusion
protein was eluted with 5 mM reduced glutathione in
equilibration buffer. Fractions containing fusion protein
were pooled and digested with 10 μg/ml TEV protease
for 6 days at 4°C. The protein sample was dialyzed to
remove glutathione and then re-applied to the GSTrap™
FF column to remove the liberated GST. The purified
protein was concentrated to 1.185 g/L with a 5000 MW
cutoff concentrator (Vivascience) and sent to Cocalico
Biologicals, Inc. for production of specific antisera in
rabbits.
Polyclonal antibodies were raised against PfBCCP-79
according to the standard immunization protocol speci-
fied by Cocalico Biologicals, Inc. Prebleeds from four
rabbits were screened for cross-reactivity to P. falci-
parum and human red blood cell antigens by western
blot analysis. The two rabbits that were least reactive
were selected for inoculation with 100 μg purified
PfBCCP-79. The rabbits were boosted with 50 μg anti-
gen on days 14, 21 and 49 after initial inoculation. Test
bleeds were performed on days 35 and 56, and were
tested for reactivity to the PfBCCP-79 antigen by wes-
tern blot analysis. Production bleeds were performed on
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days 63 and 84, and the rabbits were exsanguinated on
day 91. These antisera were used without further purifi-
cation for western blot analysis, as described below.
Plasmid constructs for expression of biotinylated
PfBCCP-79
For labeling with 35S, the GST fusion protein is undesir-
able due to the presence of multiple cysteine residues
that will incorporate the label. To address this problem,
we constructed a plasmid expressing PfBCCP-79 with a
six-histidine tag. The PfBCCP-79 gene sequence
was amplified from pTDe003 using primers BCCP4, 5’-
GGTGGTCATATGGATAATATTTTCATACCTAAT
GTTAGGAATCC-3’ and BCCP5, 5’-GGTGGTGAA
TTCTTATTCTATTATTCCTAATAAATCTCCTATT
TTAATAATTG-3’, digested with NdeI and EcoRI
(underlined) and ligated into the pET28a vector (Invitro-
gen), generating plasmid pTDe010. This plasmid con-
tains a kanamycin resistance cassette and a pMB1 origin
of replication, and produces His-tagged PfBCCP-79
under control of a T7 promoter.
Plasmid pDB1282 was a gift from Dennis Dean at Vir-
ginia Polytechnic Institute and State University (Virginia
Tech). Plasmid pDB1282 contains the Isc (Iron-Sulfur
Cluster) operon from Azotobacter vinelandii, which is
required for iron-sulfur cluster biogenesis in this organ-
ism [30]. The Azotobacter vinelandii Isc operon is com-
posed of the genes iscR, iscS, iscU, iscA, hscB, hscA, fdx
and iscX [39]. The essential genes of this cluster (iscS,
iscU, iscA, hscB, hscA and fdx) [39] were cloned into a
variant of the pARA13 expression vector [40] to form
pDB1282. Sequencing of the 5’ and 3’ splice sites sug-
gests that the Isc operon was restricted with BspHI and
ligated into the unique NcoI site of pAra13. Interest-
ingly, pDB1282 contains the seven complete genes from
iscS to iscX as well as about 200 nucleotides of a down-
stream nucleoside-diphosphate kinase (ndk). This plas-
mid contains an ampicillin resistance cassette and
produces the Isc genes under control of an arabinose-
inducible promoter.
Plasmid pCY216 [GenBank:AAD22470.1] [23] was a
gift from John Cronan at the University of Illinois at
Urbana-Champaign. It was modified from the pARA13
expression vector, and encodes E. coli BirA under con-
trol of an arabinose-inducible promoter in a chloram-
phenicol resistance plasmid containing a p15a origin of
replication.
Plasmid pRK586 [41] was modified to produce the E.
coli biotin synthase (BioB). The bioB gene was amplified
from K-12 E. coli with the primers BioB1, 5’-
GGTGGTGGTACCATGCATATGGCTCACCGCC-
CACGCTG-3’, and BioB2, 5’-GGTGGTGGATCC
GCGGCCGCTCATAATGCTGCCGCGTTGTAATAT
TC-3’. The resulting amplicon, which contained 5’ KpnI/
NsiI sites and 3’ NotI/BamHI sites (underlined), was
digested with KpnI and BamHI and ligated into pRK586
digested with the same endonucleases. The resulting
plasmid, pSPr058, was digested with BclI and SacI to
excise the kanamycin resistance gene (encoding amino-
glycoside 3’-phosphotransferase). Primers Amp1, 5’-GG
TGGTTGATCAGCCTTTTTGCGTTTCTACAAACTC-
3’ and Amp2, 5’-GGTGGTGAGCTCTTACCAATGCTT
AATCAGTGAGGC-3’ were used to amplify the ampi-
cillin resistance gene (encoding b-lactamase) and 118
upstream bases from plasmid pDB1282. The resulting
amplicon was digested with BclI and SacI (underlined)
and ligated into the pSPr058 fragment described above.
The resulting plasmid, pSPr059, encodes BioB under
control of the lPL/tetO promoter in an ampicillin resis-
tant plasmid containing a pSC101 origin of replication.
In vivo biotinylation of PfBCCP-79 and western blotting
The methionine auxotroph E. coli strain B834(DE3) (Nova-
gen) was transformed with plasmid pTDe010 (encoding
PfBCCP-79), in combination with either pSPr059 (encod-
ing BioB), pCY216 (encoding BirA) or pDB1282 (encoding
the AvIsc proteins). Transformed cells were grown to an
OD600 of 0.8 at 37°C with the appropriate antibiotics in
minimal medium composed of sulfur-free minimal E med-
ium (0.83 mM MgCl2, 9.5 mM citric acid, 58 mM
K2HPO4, 29.7 mM NH4Cl, 16.7 mM NaH2PO4) supple-
mented with 0.4% (w/v) glucose, 100 μM FeCl3, and 2 mM
methionine [42]. Protein expression was induced with 0.4
mM IPTG and 0.025% arabinose, and the BioB substrate
desthiobiotin (Sigma-Aldrich) was added at a concentra-
tion of 1 mM. Cells were grown for 10 hours at 20°C.
Cultures were normalized based on their cell density, and
equal amounts of cells were harvested by centrifugation at
16,000 g for 5 min in 1.5 ml Eppendorf tubes. Cell pellets
were lysed in NuPAGE sample buffer (Invitrogen) and vor-
texed to shear genomic DNA. For western blot analysis,
proteins were separated by sodium dodecyl sulfate polya-
crylamide gel electrophoresis (SDS-PAGE) on 4-12% bis-
tris acrylamide gradient gels. The gels were blotted onto
0.2 μm nitrocellulose membranes (Invitrogen) for 120 min
at 5 V using a Semi-Dry transfer cell (BioRad). Membranes
were blocked in 5% non-fat dry milk (Carnation) in PBS,
washed in PBS, and probed with 1:4,000 streptavidin-HRP,
ultrasensitive (Sigma-Aldrich). After PBS washes, HRP was
detected using the Supersignal® West Pico chemilumines-
cent kit (Pierce). Membranes were then stripped using 4%
(w/v) trichloroacetic acid (TCA), blocked as before, washed
in PBS, and probed with rabbit antiserum specific for
PfBCCP-79 (1:4,000). After PBS washes, the blot was
probed with 1:5,000 donkey anti-rabbit immunoglobulin
antibody conjugated to horseradish peroxidase (GE Health-
care). Excess antibody was removed with PBS, and HRP
was detected using the chemiluminescent kit.
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Expression and purification of [35S]-biotin-PfBCCP-79
For radiolabeling studies, the methionine auxotroph
E. coli strain B834(DE3) (Novagen) was transformed
with plasmids pTDe010, pSPr059 and pCY216. Cells
were cultured at 37°C in 10 mL sulfur-free minimal
medium (described above). When the culture reached
an OD600 of 0.8, expression of PfBCCP-79 and BirA
were induced with 0.4 mM IPTG and 0.025% arabinose,
respectively. The culture was transferred to 20°C, and
after one hour, 1 mCi Na35SO4 (American Radiolabeled
Chemicals, 10 mCi/ml) and 1 mM desthiobiotin were
added. The culture was maintained at 20°C for an addi-
tional 10 hours. Cells were then harvested by centrifuga-
tion for 20 min at 3,000 g and frozen at -20°C for later
purification.
Cell pellets were lysed at room temperature for
10 min in 1 mL BugBuster (Novagen) supplemented
with 1 mg/mL lysozyme and 2.5 μg/mL DNAseI. The
cell lysate was cleared by centrifugation for 5 min at
16,000 g and applied to a 1 ml HiTrap Metal Chelate
HP Column (GE Healthcare) equilibrated with Buffer A
(20 mM Na/K phosphate pH 7.5). The column was
washed with 7 mL Buffer A, and the combined flow
through was collected and labeled FT1. The column was
washed with 5 mL 30 mM imidazole in Buffer A (W1),
followed by 5 mL 1 M NaCl in Buffer A (W2), and
5 mL 1% Triton X-100 in Buffer A (W3). The metal
chelate column was then connected to a 4.6 mm × 100
mm PEEK™column (Applied Biosystems) packed with
1.7 mL SoftLink™ Soft Release Avidin Resin (Promega),
and bound proteins were eluted from the metal chelate
column with 5 mL 400 mM imidazole in Buffer A
(FT2). Both columns in tandem were washed with 8 mL
Buffer A (W4), and then the metal chelate column was
removed. Bound protein was eluted from the avidin col-
umn in 4 mL 50 mM glycine pH 2.9 (E1). 400 μl 1 M
Tris was added to the collection tube prior to eluting to
prevent damage over time from the low pH of the
elution buffer.
The purified biotinylated PfBCCP-79 protein was pre-
cipitated by adding 100% (w/v) TCA to a final concen-
tration of 10%, and centrifuging for 15 min at 16,000 g.
The resulting protein pellet was resuspended in 200 μL
5 M HCl and incubated at 95°C for 8 hours. One μL
1 g/L phenol red was added as a pH indicator, and the
resulting hydrolysate was buffered by adding 50 μL 1 M
K2HPO4, and neutralized by adding 10 M NaOH until
the pH indicator turned pink.
Verification and quantification of biologically active
[35S]-biotin in E. coli
A biotin bioassay was developed using a biotin auxo-
troph E. coli strain in which the biotin synthase
(bioB) gene had been replaced with a kanamycin
resistance cassette (National BioResource Project
(NIG, Japan):Keio JW0758). These cells were grown
to full density in LB with 50 μg/mL kanamycin. To
deplete biotin levels prior to the assay, 1 μL of the
LB culture was added to 4 mL biotin-free minimal
medium composed of minimal E medium (0.81 mM
MgSO4, 9.5 mM citric acid, 58 mM K2HPO4, 7.4 mM
(NH4)2SO4, 16.7 mM NaH2PO4) supplemented with
0.4% (w/v) glucose, 30 μM FeSO4, and 50 μg/mL
kanamycin. This culture grew to full density over a
one day period at 37°C, and 1 μL of this culture was
used to start a second 4 mL culture in biotin-free
minimal medium. This culture achieved a lower den-
sity, presumably due to the 16,000,000 fold dilution
of biotin from the original LB culture. For the bioas-
say, 2 μL of the biotin depleted culture was added to
2 mL biotin-free minimal medium supplemented
with known concentrations of biotin. Assay cultures
were grown at 37°C for 16 hours, after which the
optical density was measured at 600 nm. These cul-
tures were used to construct a standard growth
curve. Parallel cultures were supplemented with serial
dilutions of PfBCCP-79 hydrolysate. Cell densities of
cultures supplemented with the hydrolysate were
compared with the standard curve in order to quan-
tify the biologically active biotin in the hydrolysate.
In order to detect [35S]-biotin incorporation into the
E. coli BCCP protein, cells were harvested and pro-
teins were separated by SDS-PAGE, transferred to
nitrocellulose membrane and exposed to autoradio-
graphy film.
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